Trial NCT03277482

View at ClinicalTrials.gov 
Org. Study IDs: 17-382

Last trial update was posted on 2023-08-01

MeSH Interventions

Durvalumab Tremelimumab

MeSH Conditions

Carcinoma Carcinoma, Ovarian Epithelial Endometrial Neoplasms Ovarian Neoplasms Recurrence Uterine Cervical Neoplasms Vaginal Neoplasms Vulvar Neoplasms

Other Conditions

Metastatic Cervical Cancer Metastatic Endometrial Cancer Metastatic Ovarian Cancer Metastatic Vaginal Cancer Metastatic Vulvar Cancer Recurrent Cervical Carcinoma Recurrent Endometrial Cancer Recurrent Gynecological Cancer Recurrent Ovarian Carcinoma Recurrent Vaginal Cancer Recurrent Vulvar Cancer

Stopping Reasons

Expansion cohort was not open

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID